Galantamine HBr SR Pellets Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Galantamine HBr SR Pellets Manufacturer in India

Pharmaceutical-Grade Galantamine HBr SR Pellets for Sustained-Release Oral Formulations

Galantamine HBr SR Pellets are multiparticulate pharmaceutical formulations designed for sustained-release oral dosage applications. The active ingredient is Galantamine Hydrobromide, commonly abbreviated as Galantamine HBr. The anhydrous form is identified by CAS Number 1953-04-4, with molecular formula C17H22BrNO3 and molecular weight 368.27 g/mol.

The SDP pellet product portfolio lists Galantamine HBr SR Pellets at 8% strength, providing a defined active-loading option for pharmaceutical formulation development.

The sustained-release pellet format is designed to modify the release of the active ingredient over an extended period. Multiparticulate pellets can provide formulation flexibility for oral dosage forms, including suitable capsule-filling applications. Final release performance depends on pellet composition, coating system, active loading, pellet characteristics and the applicable finished-product specification.

Key Features

  • Galantamine HBr sustained-release pharmaceutical pellets
  • 8% active ingredient strength
  • Pharmaceutical-grade multiparticulate formulation
  • Sustained-release formulation platform
  • Suitable for oral dosage-form development
  • Suitable for capsule-filling applications
  • Defined active ingredient loading
  • Product-specific release characteristics
  • Formulation flexibility
  • Suitable for bulk pharmaceutical requirements

Product Information

Galantamine Hydrobromide is the hydrobromide salt of galantamine. The anhydrous form has the molecular formula C17H22BrNO3 and molecular weight 368.27 g/mol. A monohydrate form is also recognized, with CAS 1953-04-4 being associated with galantamine hydrobromide in pharmaceutical references; the exact solid form should therefore be confirmed against the raw-material specification.

For finished Galantamine HBr SR Pellets, the 8% strength represents active ingredient loading and should not be confused with the purity assay of Galantamine Hydrobromide API.

Available Strength

Galantamine HBr SR Pellets — 8%

The 8% strength is listed for Galantamine HBr SR Pellets in the referenced pharmaceutical pellet product portfolio.

Applications

Galantamine HBr SR Pellets can be considered for:

  • Sustained-release oral formulation development
  • Multiparticulate pharmaceutical formulations
  • Capsule-filling applications
  • Modified-release formulation development
  • Oral dosage-form development
  • Pharmaceutical formulation development
  • Commercial pharmaceutical manufacturing

Why Galantamine HBr SR Pellets from Swapnroop?

  • Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
  • 8% Strength: Defined active-loading option for formulation development.
  • Sustained-Release Format: Designed for sustained-release multiparticulate applications.
  • Multiparticulate Platform: Suitable for pellet-based oral dosage-form development.
  • Product-Specific Quality Control: Finished pellets can be evaluated against applicable product specifications.
  • Capsule-Filling Applications: Suitable for multiparticulate capsule formulation approaches.
  • Bulk Pharmaceutical Supply: Suitable for formulation and manufacturing requirements.

Packaging & Supply

Galantamine HBr SR Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable technical documentation can be specified according to the intended pharmaceutical formulation.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 95.0% – 105.0%
Loss on Drying NMT 0.5%
Residue on Ignition NMT 0.1%
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 0.5%
Get Bulk Quote via WhatsApp